2m 2m 2m 2m 2m 2m 2m
Surgery Partners (SGRY)
NASDAQ
$14.54-$0.02 (-0.10%)
Price as of Jun 23, 2026 4:10 PM EDT- $1.9BMarket Cap
- -27.97%1-Year Change
- Medical Care FacilitiesIndustry
Surgery Partners (SGRY)
$14.54-$0.02 (-0.10%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.3B +6.24% | 3.1B +13.52% | 2.7B +8.03% | 2.5B +14.12% | |
Cost of Revenue | 2.5B +7.39% | 2.4B +13.02% | 2.1B +6.69% | 2.0B +13.31% | |
Gross Profit | 765.0M +2.60% | 745.6M +15.15% | 647.5M +12.63% | 574.9M +16.99% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 176.0M +15.33% | 152.6M +29.21% | 118.1M +2.87% | 114.8M +16.19% | |
Total Operating Expenses | 2.9B +5.56% | 2.8B +14.50% | 2.4B +10.08% | 2.2B +14.10% | |
Operating Profit | 389.5M +11.67% | 348.8M +6.34% | 328.0M -4.98% | 345.2M +14.23% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -272.6M +35.15% | -201.7M +4.51% | -193.0M -17.84% | -234.9M +6.29% | |
Interest Income and Expense and Net | -272.6M +35.15% | -201.7M +4.51% | -193.0M -17.84% | -234.9M +6.29% | |
Total Nonoperating Income and Expense | -272.6M +35.15% | -201.7M +4.51% | -193.0M -17.84% | -234.9M +6.29% | |
Income before Taxes | 116.9M -20.53% | 147.1M +8.96% | 135.0M +22.39% | 110.3M +35.84% | |
Income Taxes | 18.0M -86.63% | 134.6M +44,966.67% | -300,000 -101.29% | 23.3M +121.90% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Net Income | -77.9M -53.66% | -168.1M +1,312.61% | -11.9M -78.21% | -54.6M -22.99% | |
Net Income from Continuing Operations Applicable to Common | -77.9M -53.66% | -168.1M +1,312.61% | -11.9M -78.21% | -54.6M -32.76% | |
Basic EPS and Net Income | -0.61 -54.14% | -1.33 +1,377.78% | -0.09 -84.75% | -0.59 -47.32% | |
Diluted EPS and Net Income | -0.61 -54.14% | -1.33 +1,377.78% | -0.09 -84.75% | -0.59 -47.32% | |
Basic Weighted Average Shares | 127.2M +0.86% | 126.1M +0.41% | 125.6M +36.61% | 92.0M +26.96% | |
Diluted Weighted Average Shares | 127.2M +0.86% | 126.1M +0.41% | 125.6M +36.61% | 92.0M +26.96% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 239.9M -10.98% | 269.5M +37.57% | 195.9M -30.75% | 282.9M -27.44% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 239.9M -10.98% | 269.5M +37.57% | 195.9M -30.75% | 282.9M -27.44% | |
Total Current Assets | 1.2B +2.80% | 1.1B +25.07% | 895.0M -2.82% | 921.0M -2.65% | |
Accumulated Depreciation | 651.2M +17.57% | 553.9M +21.90% | 454.4M +21.40% | 374.3M +37.46% | |
Property and Plant and Equipment and Net | 1.2B +5.98% | 1.1B +12.35% | 968.7M +10.51% | 876.6M +39.21% | |
Total Long-Term Assets | 56.8M -1.22% | 57.5M -44.34% | 103.3M -28.36% | 144.2M +143.99% | |
Total Assets | 8.1B +2.91% | 7.9B +14.74% | 6.9B +2.91% | 6.7B +9.23% | |
Income Taxes Payable | 53.4M +36.22% | 39.2M N/A | N/A N/A | 1.9M -91.36% | |
Total Short-Term Debt | 99.3M -2.07% | 101.4M +38.34% | 73.3M +16.72% | 62.8M +3.97% | |
Total Current Liabilities | 615.5M -1.43% | 624.4M +19.39% | 523.0M +6.00% | 493.4M -8.08% | |
Total Long-Term Debt | 3.6B +10.22% | 3.3B +20.99% | 2.7B +5.58% | 2.6B -11.10% | |
Total Long-Term Liabilities | 41.2M +36.42% | 30.2M -26.52% | 41.1M -45.49% | 75.4M -13.33% | |
Total Liabilities | 895.4M -2.30% | 916.5M +18.73% | 771.9M +0.93% | 764.8M -10.28% | |
Retained Earnings | -815.2M +10.57% | -737.3M +29.53% | -569.2M +2.14% | -557.3M +10.86% | |
Total Stockholders Equity | 1.7B -4.29% | 1.8B -9.94% | 2.0B -0.55% | 2.0B +83.49% | |
Total Shares Outstanding | 129.3M +1.74% | 127.1M +0.41% | 126.6M +0.50% | 126.0M +41.00% | |
Cash Flow | |||||
Cash from Operating Activities | 274.3M -8.60% | 300.1M +2.14% | 293.8M +85.01% | 158.8M +82.32% | |
Capital Expenditures | 78.7M -12.94% | 90.4M +1.80% | 88.8M +10.17% | 80.6M +39.93% | |
Cash from Investing Activities | -246.6M -49.52% | -488.5M +116.53% | -225.6M -26.73% | -307.9M -7.18% | |
Dividends Paid | 600,000 -93.75% | 9.6M +17.07% | 8.2M -94.41% | 146.8M +12.06% | |
Cash from Financing Activities | -57.3M -121.87% | 262.0M +268.81% | -155.2M -468.65% | 42.1M -86.69% | |
Financials Ratio | |||||
Gross Margin | 23.12% -3.43% | 23.94% +1.43% | 23.60% +4.25% | 22.64% +2.52% | |
Operating Margin | 11.77% +5.11% | 11.20% -6.33% | 11.96% -12.05% | 13.59% +0.09% | |
Return on Assets | -0.97% -57.25% | -2.28% +1,197.26% | -0.18% -79.43% | -0.85% -30.63% | |
Return on Equity | -4.45% -50.03% | -8.90% +1,390.54% | -0.60% -83.12% | -3.54% -69.95% | |
Revenue Growth | 6.24% -53.84% | 13.52% +68.34% | 8.03% -43.11% | 14.12% -28.04% | |
Current Ratio | 1.87 +4.28% | 1.79 +4.76% | 1.71 -8.32% | 1.87 +5.91% | |
Cash Ratio | 0.39 -9.68% | 0.43 +15.22% | 0.37 -34.67% | 0.57 -21.05% | |
Debt-to-Equity Ratio | 2.16 +14.77% | 1.88 +34.85% | 1.40 +6.43% | 1.31 -51.38% | |
Debt-to-Assets Ratio | 0.46 +6.74% | 0.43 +5.85% | 0.40 +2.85% | 0.39 -18.32% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow